The Global Human Chorionic Gonadotropin Market was accounted for US$ 697.3 million in 2023 and is expected to register a revenue CAGR of 8.20% to reach US$ 1,289.3 million by 2031. The Human Chorionic Gonadotropin (HCG) market is driven by increasing demand in fertility treatments, particularly in assisted reproductive technologies like ovulation induction and in vitro fertilization (IVF)....